Interview: Chloe Deutscher: Director of Business Development: PsyGen
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
Fluent Offloads Pennsylvania Dispensaries
NEW YORK – Fluent Corp. has finalized the sale of its three Pennsylvania dispensaries to HIVE Holdings Inc. for $12.5 million in cash, marking a deliberate shift toward debt reduction and operational efficiency. The deal ...
Medicare’s CBD Shift Signals Validation—But a Looming Hemp Ban Clouds the Path for Seniors
NEW YORK- For decades, seniors managing chronic pain, inflammation, anxiety, or sleep disruption have relied largely on pharmaceuticals—often with long lists of side effects. That landscape is starting to change. Medicare is preparing to recognize cannabidiol ...
DEA Increases Psychedelics Production Quotas for 2026
WASHINGTON – The Drug Enforcement Administration has approved expanded production limits for key psychedelics, setting the stage for increased scientific inquiry into substances like psilocybin and DMT next year. In a final order published Monday ...
